ProCE Banner Activity

ADCs in HER2-Mutated NSCLC

Slideset

Downloadable slideset from a live satellite symposium on the use of antibody–drug conjugates and tyrosine kinase inhibitors  in the management of HER2-mutated non-small-cell lung cancer, including recommendations on managing interstitial lung disease.

Released: September 16, 2024

Expiration: September 15, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.